Abbott Laboratories News

Abbott Laboratories Analyst Ratings

BenzingaApr 22 08:35 ET

Abbott Laboratories Analyst Ratings

BenzingaApr 18 11:52 ET

Abbott Laboratories Analyst Ratings

BenzingaApr 4 12:17 ET

Abbott Laboratories Analyst Ratings

BenzingaApr 3 11:31 ET

Abbott Laboratories Analyst Ratings

BenzingaFeb 14 09:48 ET

Edwards Stock Jumps 8% on FDA Approval, Wells Fargo Upgrade

Seeking AlphaFeb 2 12:20 ET

Abbott Laboratories Analyst Ratings

BenzingaJan 26 13:20 ET

JPMorgan Raises Abbott Laboratories Price Target to $125 From $122, Maintains Overweight Rating

MT NewswiresJan 25 07:53 ET

RBC Capital Sticks to Its Buy Rating for Abbott Labs (ABT)

TipRanksJan 25 07:26 ET

Abbott Laboratories Analyst Ratings

BenzingaJan 25 07:24 ET

RBC Capital Maintains Outperform on Abbott Laboratories, Raises Price Target to $128

BenzingaJan 11 11:08 ET

Abbott Laboratories Analyst Ratings

BenzingaJan 11 11:07 ET

Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $124

BenzingaJan 3 11:24 ET

Abbott Laboratories Analyst Ratings

BenzingaJan 3 11:23 ET

Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $121

BenzingaDec 13, 2023 10:13 ET

Abbott Laboratories Analyst Ratings

BenzingaDec 13, 2023 10:12 ET

Wells Fargo Maintains Overweight on Abbott Laboratories, Lowers Price Target to $116

BenzingaOct 19, 2023 09:36 ET

Abbott Laboratories Analyst Ratings

BenzingaOct 19, 2023 09:14 ET

Raymond James Adjusts Abbott Laboratories Price Target to $110 From $123, Maintains Outperform Rating

MT NewswiresOct 19, 2023 08:35 ET

UBS Cuts Price Target on Abbott Laboratories to $118 From $130, Keeps Buy Rating

MT NewswiresOct 16, 2023 10:08 ET